| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $499.2M | +5.4% |
| Cost of Revenue | $71.8M | +2.7% |
| Gross Profit | $427.4M | +5.8% |
| R&D Expense | $183.8M | +3.3% |
| SG&A Expense | $82.9M | +15.1% |
| Operating Income | -$117.2M | +3.3% |
| Pre-tax Income | -$86.9M | +21.6% |
| Income Tax | $14.0M | +2.2% |
| Net Income | -$100.9M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $230.7M | -37.3% |
| Short-term Investments | $253.2M | +7.1% |
| Accounts Receivable | $169.1M | +24.4% |
| Current Assets | $767.2M | -15.3% |
| Total Assets | $1.10B | +5.8% |
| Current Liabilities | $306.8M | +34.1% |
| Stockholders' Equity | $489.6M | -2.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $59.4M | +400.5% |
| Capital Expenditures | $5.1M | -55.3% |
| Investing Cash Flow | -$143.1M | +61.8% |
| Financing Cash Flow | -$53.4M | +29.3% |
| Free Cash Flow | $54.3M | — |
| +19.0% |
| EPS (Basic) | -$0.92 | +19.3% |
| EPS (Diluted) | -$0.92 | +19.3% |